Dǎɣ təbiɗawt ten, aliɣi ən adabaratan fal ACO dǎɣ alkitab ən əmik ən əmik.
Context:Ader ən ACO eqal aygan fal anyat ən musnat falas wǎr tila tabarat ən asigyik atiwazaynen dǎɣ aduniyat. Ader eqal agudiyan aygan fal asibaban ən asibaban ən asthma meɣ COPD. Corticosteroid tan win inhalation amosan asafar wa ezzaran daɣ addinat wi ilanen ACOS Corticosteroid tan win inhalation (ICS) ilzam ti ad aj in i addinat wi ilanen asthma wi idwalanen fal airway response andarran i bronchodilator tan ogdah nen id ACO Therapy addobat ad eqqil amutti s beta-agonist (LABA) d asirtay n inhalator steroid (ICS-LABA) meɣ s asiwad n inhalator n anti- muscarinic (LAMA) s axadam harkuk s isim net triple therapy, daɣ addinat wi ilanen torhinna maqqorat meɣ a orakan  Antibody tan monoclonal ijjan fal inflammation n ich-ikil wan 2 (eqqal a assohen daɣ asthma) axdaman i asafar n asthma toɣadat tolas addoben ad axdaman daɣ ihandagan n ACO toɣadat Antibody tan win monoclonal eha omalizumab (antibody wan Anti- IgE), mepolizumab (antibody wan anti- IL- 5) d benralizumab (antibody wan anti- IL- 5) Addinat wi ilanen ACOS d eosinophilia ilan alwazab ogaran hullan i ICS; id iban ajen daɣ tiw-at d ijjuch n aɣalay daɣ ACOS ijjanen ICS Corticosteroid tan win sistem (steroid tan win intravenous meɣ oral) addoben ad at w axdaman alwaq wan ACOS COPD-Asthma-COPD_overlap
- corticosteroid tan win asahat - beta- agonist (LABA) d asirtay n steroid tan win inhalat (ICS- LABA) - therapy triple (daɣ majrad iyyan, asiwad n anti-muscarinic inhaler (LAMA) - monoclonal antibodies ijjan fal inflammation n ich-ikil wan 2 - systemic corticosteroids (steroid tan ijjanen daɣ akarach meɣ oral)